Anticoagulation in children

Thrombosis Research

Volumn 130, Issue 2, 2012, Pages 142-146

  Monagle, Paul ^a,b,c,d   Newall, Fiona ^a,b,c,d  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Adolescents; Anticoagulation; Antithrombotic; Children; Neonates

Indexed keywords

ANTITHROMBIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; CANCER PATIENT; CELL INTERACTION; CONGENITAL HEART DISEASE; CONSULTATION; DRUG BINDING SITE; HUMAN; INTERNATIONAL NORMALIZED RATIO; KNOWLEDGE; PATIENT AUTONOMY; PATIENT COMPLIANCE; PATIENT EDUCATION; PEDIATRICS; PLASMA; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

ADOLESCENT; ANTICOAGULANTS; CHILD; HUMANS; INFANT, NEWBORN; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; THROMBOSIS;

EID: 84864414248     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.03.028     Document Type: Review

References (32)

1. V.H. Chan, P. Monagle, P. Massicotte, and A.K. Chan Novel paediatric anticoagulants: a review of the current literature Blood Coagul Fibrinolysis 21 2010 144 151
2. F. Newall, V. Ignjatovic, L. Johnston, R. Summerhayes, G. Lane, and N. Cranswick Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin Thromb Haemost 2010 103
3. M. Andrew, M. David, M. Adams, A. Kaiser, R. Anderson, and D. Barnard Venous thromboembolic complications (VTE) in children: first analysis of the Canadian registry of VTE Blood 83 1994 1251 1257 (Pubitemid 24062848)
4. M. Andrew Developmental hemostasis: Relevance to thromboembolic complications in pediatric patients Thromb Hemost 74 1995 415 425
5. M. Andrew, and L. Brooker Blood component therapy in neonatal hemostatic disorders Transfus Med Rev 9 1995 231 250
6. M. Andrew, B. Paes, R. Milner, M. Johnston, L. Mitchell, and D. Tollefsen Development of the human coagulation system in the full-term infant Blood 70 1987 165 172 (Pubitemid 17111257)
7. M. Andrew, P. Vegh, M. Johnston, J. Bowker, F. Ofosu, and L. Mitchell Maturation of the hemostatic system during childhood Blood 80 1992 1988 2005
8. P. Monagle, C. Barnes, V. Ignjatovic, J. Furmedge, F. Newall, and A. Chan Developmental haemostasis. Impact for clinical haemostasis laboratories Thromb Haemost 95 2006 362 372
9. P. Monagle, A. Chan, N. Goldenberg, R. Ichord, J. Journeycake, and U. Nowak-Gottl Antithrombotic therapy in neonates and children: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based clinical practice guidelines Chest 141 2012 e737S e801S
10. F. Newall, P. Monagle, H. Savioa, J. Campbell, M. Browne, and A. Greenway Anticoagulation clinics for children achieve improved warfarin management 2003 International Society of Thrombosis and Haemostasis Birmingham, UK
11. R. Summerhayes, M. Chan, V. Ignjatovic, R. Prankerd, and P. Monagle Stability and sterility of diluted enoxaparin under three different storage conditions J Paediatr Child Health 47 2011 299 301
12. S. Schedin-Weiss, B. Richard, R. Hjelm, and S.T. Olson Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence Biochemistry 47 2008 13610 13619
13. K.E. Forsten, M. Fannon, and M.A. Nugent Potential mechanisms for the regulation of growth factor binding by heparin J Theor Biol 205 2000 215 230 (Pubitemid 30662921)
14. M. Klagsbrun Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions Semin Cancer Biol 3 1992 81 87
15. X. Xu, and Y. Dai Heparin: an intervenor in cell communication J Cell Mol Med 2009
16. R.W. Niessen, R.J. Lamping, M. Peters, W.H. Lamers, and A. Sturk Fetal and neonatal development of antithrombin III plasma activity and liver messenger RNA levels in sheep Pediatr Res 39 1996 685 691 (Pubitemid 26128157)
17. F. Newall, C. Barnes, V. Ignjatovic, and P. Monagle Heparin-induced thrombocytopenia in children J Paediatr Child Health 39 2003 289 292 (Pubitemid 36714142)
18. A.N. Massaro, M. El-Dib, P. Glass, and H. Aly Factors associated with adverse neurodevelopmental outcomes in infants with congenital heart disease Brain Dev 30 2008 437 446
19. B. Farrant, and P. Watson Health care delivery: perspectives of young people with chronic illness and their parents J Paediatr Child Health 40 2004 175 179 (Pubitemid 38570267)
20. B.A. Smith, and M. Shuchman Problem of nonadherence in chronically ill adolescents: strategies for assessment and intervention Curr Opin Pediatr 17 2005 613 618 (Pubitemid 41406123)
21. S. Jones, E. Mertyn, P. Alhucema, P. Monagle, and F. Newall HEEADSSS assessment for adolescents requiring anticoagulation therapy Archives of Disease in Childhood. 97 2012 430 433
22. F. Newall, H. Savoia, J. Campbell, and P. Monagle Anticoagulation clinics for children achieve improved warfarin management Thromb Res 114 2004 5 9 (Pubitemid 38942969)
23. M.A. Rapoff Management of adherence and chronic rheumatic disease in children and adolescents Best Pract Res Clin Rheumatol 20 2006 301 314
24. J. Goldenring, and E. Cohen Getting into adolescent heads Contemp Pediatr 5 1988 75 90
25. G.C. Patton, C. Coffey, S.M. Sawyer, R.M. Viner, D.M. Haller, and K. Bose Global patterns of mortality in young people: a systematic analysis of population health data Lancet 374 2009 881 892
26. P. Monagle, A. Chan, G. de Veber, and P. Massicotte Warfarin Education Pediatric Thromboembolism and Stroke Handbook 3rd ed 2006 BC Decker Hamilton
27. J. Wiernikowski, and U. Athale Thromboembolic complications in children with cancer Thromb Res 118 2006 137 152 (Pubitemid 44262223)
28. K. Tousovska, O. Zapletal, J. Skotakova, J. Bukac, and J. Sterba Treatment of deep venous thrombosis with low molecular weight heparin in pediatric cancer patients: safety and efficacy Blood Coagul Fibrinolysis 20 2009 583 589
29. US Food and Drug Administration Invasive procedures in pediatric patients on low molecular weight heparin 1997 US Food and Drug Administration Rockville, MD
30. D. Dix, K. Charpentier, C. Sparling, and M.P. Massicotte Determination of trough anti-factor Xa levels in pediatric patients on low molecular weight heparin (LMWH) J Pediatr Hematol Oncol 20 1998 398
31. J. Douketis, A. Spyropoulos, F. Spencer, M. Mayr, A. Jaffer, and M. Eckman Perioperative management of antithrombotic therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 2012 e326S e350S
32. P. Massicotte, M. Sofronas, and G. DeVeber Difficulties in performing clinical trials of antithrombotic therapy in neonates and children Thromb Res 118 2006 153 163